Frank Diamond
Managing Editor
MANAGED CARE January 2011. ©MediMedia USA

The outcomes have been promising for some 20,000 elderly people and the insurer wants to replicate the effort in other lines of business

Managing Editor

Outcomes for about 20,000 beneficiaries in Aetna’s Medicare Advantage offering underscore that health reform’s emphasis on accountable care organizations (ACOs) could pay off in the long run — and even the short run. About three years ago Aetna pushed for a closer working relationship with doctor groups, specialists, and hospitals to create a “more accountable” way to deliver care.

“We have not created our own ACO,” says Randall S. Krakauer, MD, Aetna’s national Medicare medical director. “Rather, working with providers, we’ve created models that meet the needs and conditions of that market, similar to ACOs. We created an ACO model for the participating primary care practices.”

What it takes

Key components of this effort, which does not have an official name, include:

  • Personalized care management and support
  • Advanced technology that connects doctors with up-to-date patient information and current medical evidence
  • Financial arrangements that encourage doctors to share in the improvement of patients’ health and take into account additional time and resources needed to care for patients with chronic conditions

A case study described by the Commonwealth Fund in September 2010 showed that the program’s use of embedded case managers (nurses) reduced duplicate and unnecessary services. Compared to nonparticipating Medicare recipients, the Medicare Advantage members received 43 percent less acute hospital care in 2010.

The nurse case managers work with doctors in 36 primary care practices. Aetna pairs the doctor groups with specialists, hospitals, and community social services that can provide in-home services, home-delivered meals, caregiver support, and respite care.

“Our care management program has improved health outcomes to the advantage of everyone,” says Krakauer. “In the special case of advanced illness [end-of-life care], the impact of our specialized case management program has been dramatic.” That program was highlighted in an article in the September/October issue of Health Affairs. Krakauer was the primary author.

The study found that “the increase in hospice election and decrease in acute care services was estimated to reduce medical costs 22 percent, compared to a historical control group during the period of time members were engaged in the care management program.”

Krakauer says that Aetna was willing to make the effort worthwhile for participating providers. “Physicians and facilities earned additional payments for meeting certain quality measures that helped patients stay healthier so they can avoid more extensive care,” Krakauer says .

Expansion planned

Aetna is further putting its money behind the effort by planning to expand the program. “The work we began with the Medicare Advantage members is just a start,” says Krakauer. “The models will continue to evolve and change. We are creating a range of models similar to ACOs, including those for commercial medical plans. Our collaboration programs were, in fact, very similar to ACOs before the name went into common usage.”

“We can help a medical group with data management and case management, areas in which we have expertise,” says Randall S. Krakauer, MD, Aetna’s national Medicare medical director.

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.